Precision Oncology Solutions
for Solid Tumors

At Galaxi Genomics, we empower oncologists with comprehensive genomic profiling to guide personalized therapy decisions for patients with solid tumors. Our advanced genetic tests identify actionable mutations, fusions, and biomarkers, enabling targeted treatment strategies for improved patient outcomes.

Solid Tumor Genetic Testing Services

Breast Cancer
Breast Cancer

Assesses pathogenic variants in BRCA1/BRCA2 genes to guide tailored therapy and facilitate family risk assessment

BRCA Expanded 7 Gene Panel

Runs hereditary Breast Cancer susceptibility testing for the 7 key genes – BRCA1, BRCA2, CDH1, PALB2, PTEN, STK11, and TP53

HBOC – Hereditary Breast and Ovarian Cancer Panel

Assesses germline variants in 11 genes associated with inherited breast and ovarian cancers

Homologous Recombination Repair (HRR) Germline Panel

Detect mutations that reveal Homologous Recombination Deficiency, predicting response to therapies like PARP inhibitors

Gynecologic Oncology Inherited Cancer Panel

Detect germline oncogenic and likely oncogenic mutations (SNVs, MNVs, CNVs, InDels, Fusions, and Structural variants) in 11 genes (end to end)

Ovarian Cancer
Familial ovarian cancer Gene panel

Covers 12 Key genes – ATM, BRCA1, BRCA2, BRIP1, MLH1, MSH2, MSH6, EPCAM, PALB2, RAD51C, and RAD51D

Hereditary Breast and Ovarian Cancer Panel

 Assesses germline variants in 11 genes associated with inherited breast and ovarian cancers

HRR Germline Panel

Detect mutations that reveal Homologous Recombination Deficiency, predicting response to therapies like PARP inhibitors

Gynecologic Oncology Inherited Cancer Panel

Detect mutations (SNVs, MNVs, CNVs, InDels, Fusions, and Structural variants) in 11 genes (end to end)

Prostate Cancer

Prostate Cancer Susceptibility Testing Panel – Testing for the 5 Key genes – ATM, BRCA1, BRCA2, CHEK2, and HOXB13

Lung Cancer
Lung DNA + RNA Fusion Panel

50 gene panel to detect DNA & RNA variants (hotspot mutations, CNV genes, and fusion isoforms)

Other Solid tumors colorectal, gastric, hepatobiliary, melanoma, thyroid, cervical, endometrium etc
Cancer Hotspot 50 genes Panel
Cancer Focus 50 genes with RNA fusion Panel
Oncology 400 gene panel
Oncology 500 gene comprehensive panel (TMB + MSI + Genomic instability Matrix score (GIM))
Integrated Germline and Somatic testing
Homologous Recombination Repair (HRR) Panel

Why Choose Our Genetic Testing Services?

Who Can Benefit?

Oncologists
Seeking data-driven treatment decisions.
Pathologists
Requiring detailed molecular insights.
Cancer Patients 
Who may benefit from personalized therapy options.

Why Work With Galaxi Genomics?

Precision Genomics, Powered by Rigorous Science

At Galaxi Genomics, we combine cutting-edge NGS technology with advanced analytics to deliver clinically actionable genomic insights—helping physicians make confident, evidence-based treatment decisions.

ACMG/AMP Compliant Variant Classification
Strict adherence to clinical guidelines for consistent, reliable variant interpretation.
AI & Statistical Evidence-Driven Refinement
Enhance variant assessment with machine learning and population genomics for higher accuracy.
Actionable Reports for Clinicians
Clear, therapy-focused insights with evidence strength, drug associations, and clinical guidance.
Oncologist-Validated Solutions
Collaborate with oncologists to refine and validate genomic-based treatment strategies.
Fast, Impactful Results
Optimized workflows ensure rapid turnaround without compromising precision.
Comprehensive Evidence Backing
Leverage literature, global genomic databases, and population studies to reinforce test reliability.

Get Started Today

Enhance your oncology practice with precision genomics. Contact us to learn more about our testing options, sample requirements, and ordering process.